Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Net Margin: 2018-2025

Historic Net Margin for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Sep 2025 value amounting to -78.41%.

  • Arcturus Therapeutics Holdings' Net Margin fell 6184.00% to -78.41% in Q3 2025 from the same period last year, while for Sep 2025 it was -68.35%, marking a year-over-year decrease of 2932.00%. This contributed to the annual value of -53.14% for FY2024, which is 3532.00% down from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its Net Margin stood at -78.41% for Q3 2025, which was down 141.73% from -32.44% recorded in Q2 2025.
  • In the past 5 years, Arcturus Therapeutics Holdings' Net Margin ranged from a high of 74.02% in Q4 2022 and a low of -2,711.14% during Q1 2021.
  • Moreover, its 3-year median value for Net Margin was -37.85% (2023), whereas its average is -83.87%.
  • In the last 5 years, Arcturus Therapeutics Holdings' Net Margin slumped by 235,355bps in 2021 and then soared by 260,507bps in 2022.
  • Quarterly analysis of 5 years shows Arcturus Therapeutics Holdings' Net Margin stood at -649.72% in 2021, then soared by 72,374bps to 74.02% in 2022, then slumped by 11,187bps to -37.85% in 2023, then crashed by 9,394bps to -131.80% in 2024, then plummeted by 6,184bps to -78.41% in 2025.
  • Its last three reported values are -78.41% in Q3 2025, -32.44% for Q2 2025, and -47.91% during Q1 2025.